Dr. Reddy's Labs launches generic version of Allegra-D 12 Hour Allergy & Congestion

HYDERABAD, India - Dr. Reddy’s Labs announced Thursday that it has launched its over-the-counter fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60-mg / 120-mg, a bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion, in the U.S. market. 

 

According to the company, the Allegra-D 12 Hour brand has U.S. sales of approximately $49.8 million for the latest 52 weeks ending Oct. 6, 2014 for total U.S. multi-outlet, citing IRI.

 

Dr. Reddy’s private label version of Allergra-D 12 Hour will be available in a 20-count blister.